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Summary
We analysed a cross-sectional telephone survey of U.S. adults to assess the impact of selected 
characteristics on healthcare-seeking behaviours and treatment practices of people with influenza-
like illness (ILI) from September 2009–March 2010. Among 216,431 respondents, 8.1% reported 
ILI. After adjusting for selected characteristics, respondents 18–64 years old with the following 
factors were more likely to report ILI: a diagnosis of asthma (1.88 adjusted odds ratio [aOR]; 95% 
CI, 1.67–2.13) or heart disease (1.41 aOR; 95% CI 1.17–1.70), being disabled (1.75 aOR; 95% CI, 
1.57–1.96), and reporting financial barriers to healthcare access (1.63 aOR; 95% CI, 1.45–1.82). 
Similar associations were seen among respondents ≥65 years old. Forty percent of respondents 
with ILI sought healthcare, and 14% who sought healthcare reported receiving influenza antiviral 
treatment. Treatment was not more frequent in patients with high-risk conditions, except those 18–
64 years old with heart disease (1.90 aOR; 95% CI, 1.03–3.51). Among patients at high-risk for 
influenza complications, self-reported ILI was greater but receipt of antiviral treatment was not, 
despite guidelines recommending their use in this population.
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Introduction
During the 2009 pandemic, the Centers for Disease Control and Prevention (CDC) 
recommended early empiric influenza antiviral treatment for groups at risk for severe 
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outcomes from influenza A (H1N1)pdm09 virus infection, including persons ≥65 years old 
and persons with underlying medical conditions such as asthma, diabetes, or heart 
disease[1]. Although evidence suggests that clinicians followed Advisory Committee on 
Immunization Practices recommendations for use of antiviral agents among hospitalized 
patients[2], little is known about the propensity of high-risk persons in the community to 
seek healthcare for influenza or how frequently they received antiviral treatment.
We utilized the Behavioral Risk Factor Surveillance System (BRFSS) to describe the 
characteristics of U.S. adults reporting symptoms consistent with influenza, healthcare 
seeking behaviours, and influenza diagnosis and antiviral treatment during the 2009 
pandemic.
Methods
The BRFSS is a state-based, random-digit-dialed telephone survey among the non-
institutionalized U.S. population ≥18 years. It is the main source for state-based data on the 
prevalence of health-risk behaviours, chronic health conditions, and preventive health 
services related to chronic disease and injury; survey methodology is described 
elsewhere[3].
From September 1, 2009, to March 31, 2010, BRFSS respondents in 49 states (excluding 
Vermont), the District of Columbia (D.C.), and Puerto Rico were interviewed using a 
module designed to evaluate the presence of symptoms of influenza-like illness (ILI)[4]. 
Respondents having fever with either cough or sore throat in the 30 days preceding 
interview date were defined as having had ILIa. To determine if respondents with ILI sought 
medical care, they were asked if they had visited a healthcare professional for their illnessb. 
Respondents with ILI who sought medical care were asked about their clinical diagnosisc 
and whether they were tested for influenzad or received antiviral drugs intended for treating 
influenzae.
Self-reported characteristics included demographics, underlying medical conditions, 
behavioural characteristics, and healthcare access factors. Demographic characteristics 
evaluated were age; sex; race/ethnicity; educational attainment; and employment status. 
Underlying medical conditions evaluated were asthma; diabetes (excluding a diagnosis only 
during pregnancy); heart disease (ever having been diagnosed with myocardial infarction; 
aTo determine the presence of ILI among respondents, two questions were asked: “During the past month, were you ill with a fever?” 
If the respondent answered yes to fever in the past month they were asked “Did you also have a cough and/or sore throat?” A “Yes” 
answer to both was classified as ILI.
bTo determine if medical care was sought among those with ILI, respondents were asked: “Did you visit a doctor, nurse, or other 
health professional for this illness?”
cTo determine the clinical diagnosis, respondents were asked “What did the doctor, nurse, or other health professional tell you? Did 
they say …” and given the choice of three responses: 1. “You had regular influenza or the flu.” 2. “You had swine flu, also known as 
H1N1 or novel H1N1.” or 3. “You had some other illness, but not the flu.” A clinical diagnosis of influenza was defined as either the 
first or second response, and laboratory confirmation of influenza was not required.
dTo determine if an influenza test was administered, respondents were asked, “Did you have a flu test that was positive for this 
illness? Usually a swab from your nose or throat is tested. Would you say …” and given the choice of three responses: 1. “Yes, had flu 
test and it was positive”, 2. “No, had flu test but it was negative.”, or 3. “No, flu test was not done.” Having an influenza test 
administered was defined as either the first or second response.
eTo determine if antiviral treatment was given for the illness, respondents were asked “Did you receive Tamiflu® or oseltamivir [or an 
inhaled medicine called Relenza® or zanamivir to treat this illness?”
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angina; or coronary heart disease); the World Health Organization’s body mass index (BMI) 
classification (underweight, normal weight, overweight, obese) as calculated from self-
reported weight and height. Disability (limited because of physical, mental, or emotional 
problems or any health problem that requires the use of special equipment) was also 
recorded. Behavioural factors evaluated were smoking (current smoker [having smoked at 
least 100 cigarettes and currently smoke every day or some days], former smoker [having 
smoked at least 100 cigarettes but currently does not smoke], and never smoked [have not 
smoked at least 100 cigarettes]); binge drinking (males having ≥5 drinks on one occasion; 
females having ≥4 drinks on one occasion); and average daily alcohol consumption (non-
drinker [no alcohol], moderate drinker [≤2 drinks for men; ≤1 drink for women]; and heavy 
drinker [>2 drinks for men; >1 drink for women]). Indicators of healthcare access evaluated 
were insurance status at the time of interview among those 18–64 years old; report of having 
a personal doctor(s); and report of financial barriers to care (episodes in the past year when 
respondent needed to see a doctor but could not because of cost). Persons who reported 
current asthma, diabetes, or heart disease were defined as having had a high-risk medical 
condition.
We used SAS-callable SUDAAN® v.10 statistical software (Research Triangle Institute, 
NC) to calculate population-weighted estimates and corresponding standard errors, 95% 
confidence intervals [CI], odds ratios [OR], and p-values, taking into account the complex 
design of the BRFSS sampling plan. We used linear contrasts and chi squares to evaluate 
differences in self-reported ILI, healthcare-seeking behaviour, influenza diagnosis and 
antiviral drug receipt by selected characteristics. P values <0.05 were considered statistically 
significant. To allow for comparison among the factors evaluated, prevalence estimates were 
sex- and age-adjusted using the standard year 2000 projected U.S. population when 
appropriate[5]. Response rates for BRFSS were calculated using Council of American 
Survey and Research Organizations (CASRO) guidelines.
We examined independent associations between respondent characteristics and the report of 
ILI and receipt of antiviral treatment using logistic regression models. These models were 
stratified by age group [respondents 18–64 years old and respondents ≥65 years old] because 
the prevalence of underlying medical conditions, behavioural risk factors, and healthcare 
access differ by age[6]. We used the following candidate variables: age group; sex; race/
ethnicity; education attainment; employment status; the presence of asthma, diabetes, heart 
disease, and disability; BMI classification; smoking, binge drinking, and daily alcohol 
consumption status; insurance status (excluding persons ≥65 years old because Medicare 
serves as their primary source of reimbursement for medical care) ); report of a personal 
doctor and financial barriers to care; and report of a clinical influenza diagnosis or an 
influenza test (for the influenza treatment model only). To develop multivariable models, we 
included all candidate variables in a logistic model and removed non-significant variables 
using step-wise elimination, starting with the variable with the smallest magnitude of effect, 
until all remaining variables had Wald F p-values <0.05 or removing an additional variable 
significantly increased the -2 log likelihood of the model. We evaluated confounding by 
adding each excluded variable back into the final model individually and examining changes 
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in the β-coefficients of the included variables; if addition of one of the excluded variables 
caused a change in a β-coefficient of ≥10%, the variable was retained in the model.
Results
Report of ILI
From September 2009 through March 2010, self-reported ILI data were available from 
216,431 respondents. Median survey response rate was 55% (state range: 24%–74%), 
calculated as the percentage of persons who completed interviews among all eligible 
persons, including those who were not contacted. Median cooperation rate was 75% (state 
range: 55%–95%), calculated as the percentage of persons who completed interviews among 
all eligible persons who were contacted.
Among respondents, 8.1% reported ILI in the month before interview[4]. Compared with 
respondents not reporting ILI, those with ILI were younger and significantly more likely to 
be women, as well as less educated, unable to work, or disabled (Table 1). Respondents with 
ILI were also significantly more likely to have a high-risk condition, be current smokers or 
binge drinkers, lack health insurance, and report financial barriers to care compared to those 
who did not report ILI. Regardless of the age group examined, respondents with a high-risk 
condition reported ILI more often than respondents without a high-risk condition (p<0.01 for 
all three age groups examined; Figure 1).
Multivariable logistic regression models controlling for potential confounders identified 
several factors independently associated with greater ILI among respondents 18–64 years 
old and ≥65 years old, including a current or former diagnosis of asthma or heart disease, 
having a disability, being a current smoker, or reporting financial barriers to healthcare 
(Tables 2 and 3). Respondents 18–64 years old who were obese also had increased odds of 
reporting ILI (Table 2). After adjusting for other factors, the association between ILI and 
diabetes was increased but not significant in either age stratum.
Report of healthcare seeking
Among 14,601 respondents with ILI, 40% sought healthcare for their illness. Compared with 
respondents who did not seek healthcare, those who did were more likely to be older, 
female, and unable to work (Table 1). Several high-risk medical conditions and reported 
disability were also more common in respondents who sought healthcare. In every age 
group, respondents with high-risk conditions sought healthcare more often than respondents 
without high-risk conditions (p<0.01 for respondents aged 18–49 and 50–64 and p=0.02 for 
respondents aged ≥65 years old; Figure 1). Among respondents who sought healthcare, 32% 
reported having been tested for influenza and 42% of those tested recalled a positive 
influenza test result.
Compared with respondents who sought healthcare, those who did not were more likely to 
be current smokers; be binge, moderate, or heavy drinkers; not have health insurance or a 
personal doctor; or report financial barriers to healthcare (Table 1).
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Report of a clinical influenza diagnosis
Among 6,148 respondents with ILI who sought healthcare, 26% received a clinical 
diagnosis of influenza. None of the underlying medical conditions, behavioural, or 
healthcare access factors we analysed varied significantly between those who were and were 
not diagnosed with influenza (data not shown). However, when compared to respondents not 
receiving an influenza diagnosis, respondents receiving an influenza diagnosis were more 
likely to be younger (persons aged 18–64 years: 93.7% of respondents with an influenza 
diagnosis versus 89.5% of respondents without an influenza diagnosis; p<0.01) and Hispanic 
(Hispanic: 18.2% of respondents with an influenza diagnosis, 11.8% of respondents without 
an influenza diagnosis, p=0.02).
Report of influenza antiviral treatment
Receipt of influenza antiviral treatment was ascertained among 5,265 respondents with ILI 
who sought healthcare. Overall, 14% of respondents and 36% of respondents who received a 
clinical diagnosis of influenza received influenza antiviral treatment; those receiving 
antiviral treatment were more likely to have been tested for influenza and receive a positive 
influenza test result (Table 4). Respondents receiving antiviral treatment were also more 
likely to be younger and employed than respondents who did not receive antiviral treatment. 
No other underlying conditions, behavioural factors, or healthcare access factors were 
significantly associated with receipt of antiviral treatment. Notably, having a high-risk 
condition was not significantly associated with receiving influenza antiviral treatment, 
regardless of age group (p>0.05 for all three age groups examined; Figure 1).
Multivariable logistic regression models controlling for potential confounders found an 
almost 13-fold increased odds of influenza antiviral treatment with an influenza diagnosis 
among respondents 18–64 years old [OR, 12.7; 95% CI, 8.1 to 20.0] while the effect of an 
influenza diagnosis was less than half this value among respondents ≥65 years old [OR, 
5.50; 95% CI, 2.5 to 12.0] (see Table S1&S2). Additionally, receiving an influenza test was 
associated with greater odds of influenza antiviral treatment for both respondents 18–64 
years old [OR, 2.7; 95% CI, 1.8 to 4.1] and ≥65 years old [OR, 2.4; 95% CI, 1.1 to 5.4]. 
Respondents 25–34 years (OR, 2.1; 95% CI, 1.0 to 4.2) or who reported heart disease (OR, 
1.90; 95% CI, 1.0 to 3.5) had increased odds of receiving influenza antiviral treatment, and 
persons reporting unemployment had decreased odds of receiving influenza antiviral 
treatment [OR, 0.4; 95% CI, 0.2 to 0.88]. Respondents ≥65 years old who reported other 
employment (unemployed, homemaker, student, or retired) [OR, 0.30; 95% CI, 0.11 to 0.85] 
or having no personal doctor [OR, 0.02; 95% CI, 0.00 to 0.48] had decreased odds of 
receiving influenza antiviral treatment.
Comment
This large study of community-dwelling persons during the 2009 pandemic found that 
prevalence of ILI and healthcare seeking for ILI varied by underlying medical condition, 
behavioural factors, and healthcare access factors of respondents. In contrast, treatment of 
influenza with antiviral agents was similar among patients with and without many of the 
high-risk conditions evaluated and was decreased in unemployed and patients ≥65 years old.
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Younger adults, current smokers, and those reporting asthma, heart disease, or disability 
were more likely to report ILI, suggesting an increased susceptibility to ILI among these 
groups. Increased illness from H1N1pdm09 virus infection among younger persons is well 
documented[7, 8], but to our knowledge, no study has systematically assessed influenza 
susceptibility or the likelihood to develop ILI among those with high-risk conditions, and 
behavioural risk factors (e.g., smoking or heavy alcohol consumption)[9]. Limited evidence 
can be found in vaccine trials, community studies, or outbreak investigations, which suggest 
that smoking[10–15], asthma[16–20], obesity[19], and heart disease[21] are associated with 
either increased ILI, increased influenza, or an increased likelihood to develop ILI, although 
findings are not specific to H1N1pdm09 or the age groups evaluated in this study. 
Moreover, other studies fail to confirm these relationships[22–24].
Our results also suggest that adherence by healthcare providers to antiviral treatment 
recommendations during the pandemic was poor in the outpatient setting. Receipt of 
antiviral treatment was uncommon among adults with ILI who sought care for their illness 
and was not significantly affected by the presence of most high-risk conditions. In this 
survey, asthma, diabetes, heart disease, and age ≥65 years old was associated with greater 
healthcare seeking for ILI. However, no high-risk condition, except heart disease among 
respondents 18–64 years old, was significantly associated with greater receipt of influenza 
antiviral treatment compared to persons without these high-risk conditions. Additionally, 
although not significant, the effect of a clinical diagnosis of influenza on receipt of antiviral 
treatment among respondents ≥65 years old was half of that in respondents 18–64 years old, 
and overall proportions of influenza antiviral treatment in this age group were low. Among 
adults, these underlying medical conditions, as well as age ≥65 years, are known to increase 
the risk for complications from influenza[9]. During the 2009 pandemic, early antiviral 
treatment was recommended for persons with high-risk conditions, regardless of influenza 
severity[1]. Prompt treatment with antiviral medications has been shown to reduce the risk 
of complications from seasonal influenza[25, 26], and treatment for persons with high-risk 
conditions should not be delayed while awaiting results of diagnostic testing. In this study, 
however, the likelihood of receiving antiviral treatment was much greater among those who 
received an influenza test than those who did not, although we were unable to distinguish 
patients who received antiviral treatment concurrently with an influenza test being ordered 
from those who received treatment after an influenza test result was known. The widespread 
reports that persons ≥65 years old may have some pre-existing immunity to H1N1pdm09 
may have contributed to the reduction in influenza antiviral treatment, as well as the small 
decrease in influenza diagnosis compared to those ≤65 years old. However, an explanation 
for the lack of increased antiviral receipt among those with high-risk conditions remains 
unclear.
Less than half of respondents overall sought healthcare for ILI, and healthcare access factors 
reduced healthcare-seeking behaviour. Lacking insurance (among respondents 18–64 years 
old), a personal doctor, or the ability to afford healthcare reduced healthcare seeking 
significantly among the nearly 15,000 respondents with ILI in this study. Additionally, 
although unemployed respondents were not less likely to seek healthcare, those who did 
were less likely to receive influenza antiviral treatment. Thus, it is possible that access to 
appropriate medical care, including receipt of influenza antiviral drugs, may have been 
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affected for some persons by their healthcare access or employment status. Unemployment 
and lack of medical insurance have been associated with delayed or missed medical care or 
prescriptions because of cost[27, 28] while adults with a personal doctor experience 
improved health outcomes[29]. Furthermore, the U.S. unemployment rate may be associated 
with increased state reports of widespread influenza[30], and more severe outcomes from 
seasonal and H1N1pdm09 influenza infection have been observed in high poverty areas[31, 
32]. If receipt of appropriate medical care was affected by access to healthcare or 
unemployment status, then the 10% of adults who reported unemployment[33], the 15% of 
adults who reported foregoing medical care because of cost[34], and the almost 18% of 
persons 18–64 years old who reported a lack of health insurance[34] during the 2009 
pandemic could represent an unexplored risk group. To prepare for future pandemics, a 
better understanding of how reduced healthcare access may affect the appropriate treatment 
of persons with ILI is needed.
Interestingly, we also found that respondents who reported financial barriers to healthcare 
were more likely to report ILI, even after controlling for age, medical conditions, and 
employment. The reasons for this are unclear, but adults who report financial barriers to 
healthcare are more likely to have chronic conditions or poor health status[35]. Therefore, 
these respondents may have had other chronic conditions not evaluated in this study that 
place them at increased risk for influenza or may represent persons with poorly controlled 
chronic medical conditions.
This report is subject to several limitations. First, data in this study are self-reported and 
subject to recall and social desirability bias. Therefore, report of a clinical diagnosis of 
influenza or receiving an influenza diagnostic test may not represent actual clinical practice 
or decision-making. However, most estimates for chronic disease prevalence and high-risk 
behaviours from the BRFSS are similar when compared to other national surveys[36]. 
Additionally, the trends in ILI and receipt of influenza antiviral treatment in this report are 
similar to independent U.S. estimates of the number of H1N1pdm09 cases and the number 
of antiviral drug prescriptions filled for the treatment of influenza[7, 37]. Second, we only 
assessed risk factors available in the BRFSS during the 2009–10 influenza season; we did 
not have information on other medical conditions known to confer increased risk for 
complications from influenza, which range in prevalence from <1%–4.4% in the U.S. adult 
population [9, 38]. Therefore, some persons with high-risk conditions could be misclassified 
as having no high-risk medical conditions. However, we included those who reported any 
type of disability to capture some of these persons[39]. Third, we did not ascertain the 
duration between illness onset and first healthcare encounter for persons reporting ILI. 
Effectiveness of influenza antiviral treatment declines between 2–7 days after illness onset 
[9], and physicians may be less likely to prescribe antiviral treatment to individuals 
presenting during this period. Thus, the proportion of respondents receiving influenza 
antiviral treatment we report may underestimate the fraction that would have been treated if 
presenting earlier. The 2010–11 BRFSS ILI survey contains the time from illness onset to 
first healthcare encounter; inclusion of these data will help address this weakness in future 
analyses. Fourth, BRFSS data are collected only from households with a landline telephone, 
and our study is subject to selection bias resulting from exclusion of households with only 
cellular phones[40]. Finally, the BRFSS is a household survey that does not collect 
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information from persons in institutions, nursing homes, long-term-care facilities, and 
correctional institutions. Therefore, the results presented in this analysis do not generalize to 
these populations.
In conclusion, our findings suggest a higher risk for symptomatic influenza in persons with 
certain underlying medical conditions, behavioural factors, and healthcare access 
restrictions. It also identified areas of the 2009 pandemic response that could have been 
improved. Despite recommendations to administer prompt antiviral treatment to high-risk or 
persons ≥65 years old with suspected or confirmed influenza, receipt of influenza antivirals 
was not significantly higher for these groups. The data on antiviral use among high-risk or 
persons ≥65 years old presented in this report can inform communication efforts to 
physicians who care for these populations and improve compliance with antiviral treatment 
guidance. Finally, reduced healthcare access observed in this report may have delayed or 
prevented appropriate medical care for some respondents with ILI; future pandemic 
planning efforts should consider individual barriers to health care when designing response 
strategies.
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Figure 1. 
Comparison among adults ≥18 years old with and without high-risk conditions of influenza-
like illness, healthcare seeking for ILI, and influenza antiviral receipt among those who 
sought care, by age group, Behavioral Risk Factor Surveillance System, September 1, 2009 
–March 31, 2010.
*Respondent ever told they had myocardial infarction, angina, coronary heart disease, 
current asthma, or diabetes
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Table 2
Characteristics associated with ILI among respondents 18–64 years old in multivariable analysis, Behavioral 
Risk Factor Surveillance System. September 1, 2009 –March 31, 2010.
Characteristics Adjusted Odds Ratio (95% CI)
Age group (in years)
18 to 24 2.47 (2.04–2.99)
25 to 34 2.04 (1.78–2.34)
35 to 44 1.66 (1.46–1.88)
45 to 54 1.33 (1.19–1.48)
55 to 64 REF
Sex
Female 1.29 (1.17–1.41)
Male REF
Race/Ethnicity
Black, NH 0.75 (0.63–0.90)
Hispanic 0.92 (0.78–1.08)
American Indian/Alaska Native 1.73 (1.17–2.57)
Other, NH 1.11 (0.91–1.36)
White, NH REF
Level of education
>High school 0.90 (0.76–1.05)
High school graduate 0.92 (0.83–1.02)
Some college/grad college REF
Employment status
Unable to work 1.09 (0.94–1.27)
Unemployed 0.95 (0.81–1.11)
Homemaker 0.92 (0.78–1.07)
Student 0.97 (0.75–1.24)
Retired 0.76 (0.63–0.91)
Employed REF
Asthma
Current asthma 1.88 (1.67–2.13)
Former asthma 1.43 (1.17–1.75)
Never asthma REF
Diabetes
Yes 1.15 (0.99–1.34)
No REF
Disability
Yes 1.76 (1.57–1.96)
No REF
Heart disease
Yes 1.41 (1.17–1.70)
No REF
Weight status
Underweight 0.82 (0.60–1.14)
Overweight 0.96 (0.86–1.08)
Obese 1.15 (1.03–1.29)
Normal weight REF
Smoking status
Current 1.41 (1.27–1.57)
Former 1.00 (0.90–1.11)
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Characteristics Adjusted Odds Ratio (95% CI)
Never REF
Binge drinker
Yes 1.05 (0.91–1.21)
No REF
Heavy drinker
Moderate 1.09 (0.98–1.20)
Heavy 1.11 (0.89–1.39)
Nondrinker REF
Health insurance
No 0.94 (0.81–1.08)
Yes REF
Personal doctor
None 0.89 (0.78–1.01)
One or more REF
Financial barrier to care
Yes 1.63 (1.45–1.82)
No REF
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Table 3
Characteristics associated with ILI among respondents ≥65 years, Behavioral Risk Factor Surveillance 
System. September 1, 2009 –March 31, 2010.
Characteristics Adjusted Odds Ratio (95% CI)
Age group (in years)
65 to 74 1.78 (1.48–2.16)
≥75 REF
Sex
Female 1.36 (1.13–1.64)
Male REF
Race/Ethnicity
Black, NH 0.74 (0.51–1.09)
Hispanic 0.94 (0.64–1.40)
American Indian/Alaska Native 2.69 (1.17–6.15)
Other, NH 1.18 (0.70–1.98)
White, NH REF
Level of education
>High school 1.08 (0.83–1.39)
High school graduate 0.87 (0.72–1.04)
Some college/grad college REF
Employment status
Unable to work 1.39 (0.93–2.07)
Unemployed, Homemaker Student, or Retired 0.89 (0.71–1.12)
Employed REF
Asthma
Current asthma 2.74 (2.24–3.36)
Former asthma 1.52 (1.02–2.25)
Never asthma REF
Diabetes
Yes 1.18 (0.97–1.42)
No REF
Disability
Yes 1.73 (1.45–2.05)
No REF
Heart disease
Yes 1.54 (1.27–1.85)
No REF
Smoking status
Current 1.74 (1.32–2.30)
Former 1.21 (1.01–1.45)
Never REF
Binge drinker
Yes 0.66 (0.39–1.11)
No REF
Heavy drinker
Moderate 0.96 (0.79–1.16)
Heavy 0.48 (0.27–0.86)
Nondrinker REF
Personal doctor
None 0.71 (0.51–1.00)
One or more REF
Financial barrier to care
Yes 1.71 (1.32–2.23)
No REF
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Table 4
Age and sex adjusted prevalence of characteristics of adults with ILI who sought healthcare who did and did 
not report receipt of influenza antiviral drugs, Behavioral Risk Factor Surveillance System. September 1, 2009 
–March 31, 2010.
Receipt of influenza antiviral drugs
Characteristics
Yes
n=620
No
n=4645
p value
Yes vs. No
% (SE)
Age group Age ≥65 years olda 5.29 (0.94) 9.26 (0.58) <0.01
Sex Malea 33.0 (3.57) 34.8 (1.65) 0.65
Race/Ethnicity
White, Non-Hispanic (NH) 66.5 (3.55) 71.8 (1.78) 0.18
Black, NH 7.9 (1.51) 9.6 (1.37) 0.40
Hispanic 16.9 (3.09) 11.7 (1.29) 0.12
American Indian/Alaska Native NAb NAb --
Level of education
Less than high school 15.3 (2.80) 12.4 (1.07) 0.32
High school graduate 32.5 (3.26) 31.7 (1.56) 0.83
Some college/college grad or more 52.1 (3.54) 55.9 (1.69) 0.34
Employment status
Employed 51.3 (3.34) 51.7 (1.64) 0.91
Unemployed 5.8 (1.34) 10.5 (1.36) 0.01
Unable to work 12.1 (1.77) 13.1 (0.89) 0.61
Homemaker 8.9 (1.77) 5.46 (0.48) 0.06
Student 8.3 (2.51) 4.9 (0.84) 0.20
Retired 13.6 (1.59) 14.3 (0.55) 0.68
Underlying condition
No chronicc 65.5 (3.01) 62.9 (1.36) 0.42
Current asthma 20.5 (2.76) 21.2 (1.09) 0.83
Diabetes 14.4 (2.05) 13.3 (0.87) 0.64
Heart disease 13.0 (1.88) 11.6 (0.73) 0.48
Any chronicd 34.5 (3.01) 37.1 (1.36) 0.42
Disability 40.5 (3.36) 39.1 (1.45) 0.72
Weight status
Underweight 1.93 (0.74) 1.52 (0.25) 0.59
Normal weight 27.9 (3.25) 30.0 (1.67) 0.57
Overweight 35.6 (3.48) 31.6 (1.63) 0.30
Obese 34.6 (3.43) 36.9 (1.62) 0.54
Pregnancy Pregnanta NAb NAb --
Smoking status
Current smoker 26.8 (3.36) 23.9 (1.29) 0.42
Former smoker 22.1 (2.40) 26.6 (1.32) 0.10
Never smoked 51.0 (3.47) 49.6 (1.64) 0.70
Alcohol use
Binge Drinker 16.5 (2.84) 13.3 (1.20) 0.29
Non-drinker 56.4 (3.36) 55.4 (1.70) 0.78
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Receipt of influenza antiviral drugs
Characteristics
Yes
n=620
No
n=4645
p value
Yes vs. No
% (SE)
Moderate drinker 41.0 (3.37) 40.4 (1.72) 0.87
Heavy drinker 2.6 (0.90) 4.2 (0.76) 0.16
Healthcare access
No insurance 18–64a 12.2 (2.75) 13.5 (1.35) 0.68
No personal doctor 6.9 (1.52) 10.0 (1.13) 0.10
Financial barrier to care 19.9 (2.92) 19.5 (1.21) 0.90
Clinical diagnosis Received influenza dx 75.3 (3.05) 22.9 (1.55) <0.01
Diagnostic testing
Tested for influenza 54.1 (3.60) 27.0 (1.60) <0.01
Tested + for influenzae 77.8 (3.29) 28.4 (3.05) <0.01
a
Estimate not age and sex adjusted since variable includes an age or sex component
b
Estimate unavailable because the un-weighted sample size for the denominator is<50 or the CI half width is >10.
c
Respondent never told they had myocardial infarction, angina, coronary heart disease, current asthma, or diabetes
d
Respondent ever told they had myocardial infarction, angina, coronary heart disease, current asthma, or diabetes
eAmong respondents who reported an influenza test
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